PubRank

Young Mog Shim

Author PubWeight™ 152.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 2007 2.91
2 Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013 2.52
3 A comparative analysis of video-assisted mediastinoscopy and conventional mediastinoscopy. Ann Thorac Surg 2011 2.23
4 Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005 2.19
5 Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008 2.17
6 Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol 2015 2.17
7 Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Ann Surg 2013 1.76
8 Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006 1.72
9 Video-assisted thoracic surgery lobectomy: single institutional experience with 704 cases. Ann Thorac Surg 2010 1.68
10 Descending necrotizing mediastinitis: a minimally invasive approach using video-assisted thoracoscopic surgery. Ann Thorac Surg 2004 1.63
11 Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 2009 1.61
12 Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2003 1.55
13 Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006 1.54
14 Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol 2004 1.50
15 Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol 2009 1.50
16 Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003 1.49
17 Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010 1.47
18 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006 1.46
19 Dry pleural dissemination in non-small cell lung cancer: prognostic and diagnostic implications. Radiology 2011 1.46
20 Change of junctions between stations 10 and 4 in the new International Association for the Study of Lung Cancer Lymph Node Map: a validation study from a single, tertiary referral hospital experience. Chest 2015 1.43
21 Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. J Clin Oncol 2013 1.40
22 Pleural recurrence and long-term survival after thoracotomy and thoracoscopic lobectomy. Ann Thorac Surg 2013 1.40
23 Pharyngo-colostomy with supraglottic partial laryngectomy in caustic oropharyngeal stricture. Ann Thorac Surg 2006 1.39
24 Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Cancer 2006 1.36
25 Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010 1.35
26 Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol 2012 1.34
27 Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 2007 1.32
28 Primary leiomyoma of the trachea, bronchus, and pulmonary parenchyma--a single-institutional experience. Eur J Cardiothorac Surg 2012 1.32
29 Primary salivary gland-type lung cancer: surgical outcomes. Lung Cancer 2010 1.32
30 Giant fibrovascular polyp of the hypopharynx: surgical treatment with the biappoach. J Korean Med Sci 2006 1.32
31 Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 2003 1.29
32 The spectrum of benign esophageal lesions: imaging findings. Korean J Radiol 2002 1.27
33 High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. Histol Histopathol 2012 1.26
34 Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010 1.24
35 Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 2005 1.23
36 Unplanned conversion to thoracotomy during video-assisted thoracic surgery lobectomy does not compromise the surgical outcome. World J Surg 2011 1.22
37 Treatment outcomes for patients with synchronous multiple primary non-small cell lung cancer. Lung Cancer 2010 1.21
38 Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis 2006 1.20
39 Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013 1.19
40 Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res 2006 1.16
41 Treatment of inflammatory myofibroblastic tumor of the chest: the extent of resection. Ann Thorac Surg 2007 1.15
42 Surgical treatment for multidrug-resistant and extensive drug-resistant tuberculosis. Ann Thorac Surg 2010 1.15
43 Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2013 1.14
44 Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004 1.14
45 EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. PLoS One 2013 1.13
46 Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients. AJR Am J Roentgenol 2007 1.13
47 Radiographic and CT findings in complications following pulmonary resection. Radiographics 2002 1.12
48 Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung. Oncology 2011 1.10
49 Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004 1.10
50 Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer 2012 1.09
51 Factors determining successful computed tomography-guided localization of lung nodules. J Thorac Cardiovasc Surg 2011 1.09
52 Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer 2009 1.08
53 Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010 1.08
54 Usefulness of open lung biopsy in mechanically ventilated patients with undiagnosed diffuse pulmonary infiltrates: influence of comorbidities and organ dysfunction. Crit Care 2007 1.06
55 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 2004 1.06
56 Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. Ann Surg Oncol 2006 1.06
57 Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study. Radiology 2006 1.03
58 A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma. Cancer Chemother Pharmacol 2007 1.02
59 Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer 2008 1.01
60 Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 2005 1.00
61 Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol 2003 0.99
62 Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol 2009 0.99
63 Public attitudes toward cancer and cancer patients: a national survey in Korea. Psychooncology 2012 0.99
64 Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer. J Thorac Oncol 2010 0.99
65 CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma. Int J Cancer 2008 0.98
66 Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer 2005 0.98
67 Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 2014 0.98
68 Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma. Eur J Cancer 2006 0.96
69 Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer. Cancer Res 2003 0.96
70 ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. Cancer 2008 0.96
71 The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet 2011 0.96
72 Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2007 0.95
73 Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers. Radiology 2012 0.93
74 Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res 2013 0.93
75 Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003 0.92
76 Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J Thorac Cardiovasc Surg 2007 0.91
77 Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial. Cancer 2013 0.91
78 Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. J Thorac Oncol 2009 0.91
79 Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapy. Ann Surg Oncol 2014 0.90
80 Intrapulmonary bronchogenic cyst: CT and pathologic findings in five adult patients. AJR Am J Roentgenol 2002 0.90
81 Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005 0.90
82 The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging. J Thorac Imaging 2003 0.90
83 Treatment of congenital cystic adenomatoid malformation: should lobectomy always be performed? Ann Thorac Surg 2008 0.90
84 Analysis of 1,067 cases of video-assisted thoracic surgery lobectomy. Korean J Thorac Cardiovasc Surg 2011 0.89
85 Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer. Lung Cancer 2006 0.88
86 Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray. Cancer 2010 0.88
87 Long-term results of surgical treatment in benign bronchoesophageal fistula. J Thorac Cardiovasc Surg 2007 0.88
88 Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery. Cancer Chemother Pharmacol 2014 0.87
89 High dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancer. Yonsei Med J 2012 0.87
90 Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery. Lung Cancer 2012 0.87
91 Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2010 0.87
92 Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria. J Korean Med Sci 2008 0.86
93 Response evaluation after neoadjuvant chemoradiation by positron emission tomography-computed tomography for esophageal squamous cell carcinoma. Cancer Res Treat 2013 0.85
94 Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer. Ann Thorac Surg 2013 0.85
95 FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications. Korean J Radiol 2008 0.85
96 A modified Nuss procedure for late adolescent and adult pectus excavatum. World J Surg 2010 0.84
97 Treatment outcomes of patients with adenoid cystic carcinoma of the airway. Lung Cancer 2010 0.84
98 Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes. Am J Surg Pathol 2015 0.84
99 A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer. Eur Radiol 2012 0.84
100 Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res 2013 0.84
101 A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors. J Thorac Oncol 2013 0.83
102 Carinal resection and reconstruction in thoracic malignancies. J Surg Oncol 2014 0.83
103 Surgical treatment for pulmonary artery sarcoma. Eur J Cardiothorac Surg 2008 0.83
104 (18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients. Korean J Radiol 2008 0.83
105 Pulmonary disease caused by Mycobacterium xenopi: the first case in Korea. Yonsei Med J 2007 0.83
106 A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers. Cancer 2011 0.83
107 Health-related quality of life in disease-free survivors of surgically treated lung cancer compared with the general population. Ann Surg 2012 0.82
108 Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography. J Thorac Oncol 2011 0.82
109 Thoracic epidural anesthesia does not improve the incidence of arrhythmias after transthoracic esophagectomy. Eur J Cardiothorac Surg 2005 0.82
110 Esophageal squamous cell carcinoma recurring as a solitary renal mass. Cancer Res Treat 2004 0.82
111 Type B thymoma: is prognosis predicted only by World Health Organization classification? J Thorac Cardiovasc Surg 2009 0.82
112 HOXA11 hypermethylation is associated with progression of non-small cell lung cancer. Oncotarget 2013 0.82
113 Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 2007 0.82
114 Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma. J Thorac Oncol 2015 0.82
115 Surgical resection of recurrent lung cancer in patients following curative resection. J Korean Med Sci 2006 0.81
116 Clinical characteristics and feasibility of thoracoscopic approach for congenital cystic adenomatoid malformation in adults. Eur J Cardiothorac Surg 2007 0.81
117 En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas. J Cardiothorac Surg 2011 0.81
118 Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer. Lung Cancer 2012 0.80
119 Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer. Ann Surg Oncol 2012 0.80
120 Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers. J Magn Reson Imaging 2013 0.80
121 Primary gastric cancer in an oesophageal gastric graft after oesophagectomy. Eur J Cardiothorac Surg 2011 0.80
122 Stage III thymic epithelial neoplasms are not homogeneous with regard to clinical, pathological, and prognostic features. J Thorac Oncol 2009 0.80
123 Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma. Cancer 2013 0.80
124 Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes. Acad Radiol 2012 0.80
125 Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 2010 0.79
126 Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis. PLoS One 2013 0.79
127 Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type. J Korean Med Sci 2004 0.79
128 Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J Thorac Imaging 2002 0.79
129 Predicting recurrence using the clinical factors of patients with non-small cell lung cancer after curative resection. J Korean Med Sci 2009 0.78
130 Main bronchial reconstruction with sparing of pulmonary parenchyma for benign diseases. J Korean Med Sci 2006 0.78
131 Incremental value of PET/CT Over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis. AJR Am J Roentgenol 2010 0.78
132 Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer? Lung Cancer 2006 0.78
133 Integrated PET/CT and the dry pleural dissemination of peripheral adenocarcinoma of the lung: diagnostic implications. J Comput Assist Tomogr 2005 0.78
134 Employment status and work-related difficulties in lung cancer survivors compared with the general population. Ann Surg 2014 0.78
135 Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur J Cardiothorac Surg 2002 0.78
136 Real world impact of epidermal growth factor receptor mutation status on treatment patterns in patients with non-small cell lung cancer. Lung Cancer 2013 0.78
137 Diagnosis and treatment of metachronous gastric cancers after surgical treatment for esophageal squamous cell carcinoma. Hepatogastroenterology 2008 0.78
138 Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor? Cancer Res Treat 2012 0.77
139 Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer. World J Surg 2012 0.77
140 Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer. J Cancer Res Clin Oncol 2006 0.77
141 Delayed bronchostenosis after blunt chest trauma in children: CT and pathologic findings. J Korean Med Sci 2006 0.77
142 Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. J Nucl Med 2014 0.77
143 Aggressive gastrointestinal stromal tumour of the oesophagus with homozygous KIT exon 11 deletion mutation. Pathology 2012 0.76
144 Comparison of uptake characteristics and prognostic value of 201Tl and 18F-FDG in esophageal cancer. World J Surg 2008 0.75
145 Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer. J Korean Med Sci 2006 0.75
146 Surgical treatment of non-small cell lung cancer with isolated synchronous brain metastases. J Korean Med Sci 2006 0.75
147 Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography. Medicine (Baltimore) 2016 0.75
148 Esophageal malignancy and staging. Semin Roentgenol 2013 0.75
149 New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma. Ann Surg 2015 0.75
150 The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery. Cancer Res Treat 2003 0.75
151 Validation of the IASLC Residual Tumor Classification in Patients with Stage III-N2 Non-small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery. Ann Surg 2022 0.75
152 Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer. Cancer Lett 2008 0.75
153 Outcome of free jejunal transfer using the end-to-side arterial anastomosis technique as a pharyngo-oesophageal substitute: a 15-year experience. Eur J Cardiothorac Surg 2013 0.75